Back to Search Start Over

Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder

Authors :
Jha, Manish K.
Minhajuddin, Abu
Chin Fatt, Cherise
Kircanski, Katharina
Stringaris, Argyris
Leibenluft, Ellen
Trivedi, Madhukar H.
Source :
Neuropsychopharmacology; December 2020, Vol. 45 Issue: 13 p2147-2154, 8p
Publication Year :
2020

Abstract

Irritability in pediatric samples is associated with higher rates of subsequent suicide-related outcomes. No study, to date, has evaluated the longitudinal association between irritability and suicidal ideation (SI) in adults with major depressive disorder (MDD). This report evaluated whether irritability is associated with SI at the same visit (i.e., concurrently) and whether early changes in irritability with antidepressant treatment predict subsequent levels of SI. Participants of Combining Medications to Enhance Depression Outcomes (CO-MED, n= 665), Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC, n= 296), and Suicide Assessment Methodology Study (SAMS, n= 266) were included. Repeated-measures mixed model analyses evaluated concurrent association throughout the trial between irritability (five-item irritability domain of Concise Associated Symptom Tracking scale) and SI (three-item suicidal thoughts factor of Concise Health Risk Tracking scale) after controlling for overall depression (excluding suicidality-related item), and predicted subsequent levels of SI (repeated observations from week-2-to-week-8) based on early (baseline-to-week-2) changes in irritability after controlling for early changes in overall depression. Higher irritability was associated with higher SI concurrently; estimates (standard error) were 0.18 (0.02, p< 0.0001), 0.64 (0.02, p< 0.0001), and 0.26 (0.04, p< 0.0001) in CO-MED, EMBARC, and SAMS respectively. Greater baseline-to-week-2 reductions in irritability predicted lower levels of subsequent SI; estimates (standard errors) were −0.08 (0.03, p= 0.023), −0.50 (0.05, p< 0.0001), and −0.12 (0.05, p= 0.024) in CO-MED, EMBARC, and SAMS, respectively. Controlling for anxiety or insomnia produced similar results. In conclusion, irritability and SI were consistently linked in adults with MDD. These findings support careful assessment of irritability in suicide risk assessment.

Details

Language :
English
ISSN :
0893133X and 1740634X
Volume :
45
Issue :
13
Database :
Supplemental Index
Journal :
Neuropsychopharmacology
Publication Type :
Periodical
Accession number :
ejs53843848
Full Text :
https://doi.org/10.1038/s41386-020-0769-x